Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kamada Receives Additional Shire Milestone | Contract Pharma

What are you searching for?

Sign in

Kamada Receives Additional Shire Milestone

Achieves sales milestone in GLASSIA supply and distribution agreement

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Kamada Ltd., a plasma-derived protein therapeutics company, received an undisclosed additional milestone payment under its supply and distribution agreement with Shire for GLASSIA, Kamada’s intravenous (IV) alpha-1 antitrypsin (AAT). The payment was triggered by Shire achieving a sales milestone for GLASSIA in the U.S.

Shire is Kamada’s strategic partner for the exclusive supply and distribution of GLASSIA for all intravenous (IV) indications in the U.S., Canada, Australia, and New Zealand. The companies’ most recent contract extension, signed in October 2016, represented the fourth contract extension for the manufacture and supply of GLASSIA. Kamada’s minimum revenue for GLASSIA for the years 2017 to 2020 will reach approximately $237 million, and may be expanded to as much as $288 million during that period.

“We are pleased to receive this milestone payment,” said Amir London, chief executive officer of Kamada.  “Shire continues to achieve the sales milestones related to GLASSIA under our agreement, indicating the growing demand for the product in the U.S.  This trend continues to support our ability to achieve our forecast to grow Kamada’s total revenue to $100 million this year out of which $76 to $78 million will come from our Proprietary Products segment representing at least 36% growth year-over-year compared to 2016.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters